|1.||Cozzi, Paul J: 3 articles (12/2012 - 11/2006)|
|2.||Li, Yong: 3 articles (12/2012 - 11/2006)|
|3.||Mukhtar, Hasan: 3 articles (10/2006 - 02/2006)|
|4.||Vessella, Robert L: 2 articles (04/2009 - 05/2003)|
|5.||Madigan, Michele C: 2 articles (09/2008 - 11/2006)|
|6.||Russell, Pamela J: 2 articles (09/2008 - 11/2006)|
|7.||Reagan-Shaw, Shannon: 2 articles (10/2006 - 02/2006)|
|8.||Adhami, Vaqar Mustafa: 2 articles (10/2006 - 02/2006)|
|9.||Saleem, Mohammad: 2 articles (10/2006 - 02/2006)|
|10.||Sarfaraz, Sami: 2 articles (10/2006 - 04/2006)|
03/01/2005 - "Due to the similarities between human CaP tumors and the PSP-KIMAP tumors, this preclinical model may supplement the current transgenic models to study CaP more accurately."
03/01/2005 - "In this study, we demonstrate that the new model possesses a tumor architecture of heterogeneity and multifocality similar to that of human CaP, by utilizing a new compound scoring system to compare with the PSP94 (approved gene symbol Msmb) gene-directed transgenic mouse CaP model (TGMAP). "
03/01/2011 - "Here we show that Prx1 is overexpressed in human CaP specimens and that it regulates prostate tumor growth through TLR4-dependent regulation of prostate tumor vasculature. "
01/01/1981 - "Separation of T and NK cells is necessary to ascertain the effector cell responsible for the in vitro killing of tumor cells derived from human CaP."
07/01/2001 - "ILK immunostaining is specifically increased in high-grade, primary human CaP relative to adjacent benign prostatic hyperplasia (P < 0.001), benign prostatic hyperplasia from patients without cancer (P < 0.002), and low-grade CaP (P = 0.003). "
01/01/2006 - "This study used a new mouse histological grading system similar to the human Gleason grading system and flow cytometry DNA analysis to measure and compare the new KIMAP model with human CaP and transgenic mouse adenocarcinoma prostate (TGMAP) model. "
02/01/2006 - "The expression patterns of matriptase and HAI-1 were determined in primary cultures of normal human prostate epithelial (NHPE) cells, human CaP cells LNCaP, DU-145, CWR22Rnu1, and PC-3, and in tissue samples of 172 patients with normal prostate, benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia (PIN), and adenocarcinoma of different tumor grades. "
|3.||Lung Neoplasms (Lung Cancer)
|4.||Neoplasm Metastasis (Metastasis)
01/01/2014 - "Finally, there was a correlation between FOXO4, but not FOXO1 or FOXO3, downregulation and decreased metastasis-free survival in human CaP patients. "
04/01/2011 - "These results suggest that SPA-1 plays an important role in controlling metastasis efficiency of human CaP by regulating the expression of and interaction with ECM in the primary sites."
04/01/2011 - "The correlation was recapitulated in human CaP cell lines; LNCaP that rarely showed metastasis in SCID mice expressed an undetectable level of SPA-1, whereas highly metastatic PC3 showed abundant SPA-1 expression. "
05/01/2010 - "This review will discuss their putative roles in CaP metastasis and MDR, and give an overview of literature regarding their expression on human CaP tissues. "
10/03/2006 - "Our data demonstrate that the S100A4 gene controls the invasive potential of human CaP cells through regulation of MMP-9 and that this association may contribute to metastasis of CaP cells. "
|5.||Prostatic Neoplasms (Prostate Cancer)
01/01/2006 - "Sixty KIMAP and 48 TGMAP prostate cancer samples were measured and compared with human CaP. "
12/15/1998 - "The human prostate cancer (CaP) xenograft, CWR22, mimics human CaP. "
01/01/2004 - "Here, a hypothesis is put forward that Plk 1 plays a critical role in the development of prostate cancer; and the silencing of Plk1 will result in elimination of human CaP cells via an inactivation of cyclin-dependent kinase 1 (Cdc2)/cyclin B 1-mediated mitotic arrest followed by apoptosis. "
09/01/2008 - "We investigated EMMPRIN expression in human prostate cancer (CaP) tissues and cells, and evaluated whether EMMPRIN expression is related to tumor progression and matrix metalloproteinase (MMPs) expression in human CaP. "
|1.||Small Interfering RNA (siRNA)
|3.||Guanosine Triphosphate (GTP)
|4.||DNA (Deoxyribonucleic Acid)
|6.||epigallocatechin gallate (epigallocatechin-3-gallate)
|8.||CD147 Antigens (Basigin)
|9.||Proteasome Endopeptidase Complex (Proteasome)
|1.||Heterologous Transplantation (Xenotransplantation)